Updated Jul 16, 2026
Azamian Bobak R. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $3.61M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 5.4K | $61.81 | $335K |
| 2026-06-22 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 4.6K | $61.24 | $281K |
| 2026-03-19 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 12.0K | $67.00 | $802K |
| 2026-03-19 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 11.7K | $68.71 | $802K |
| 2026-03-19 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 11.0K | $69.42 | $762K |
| 2026-03-17 | TARS | Tarsus Pharmaceuticals, Inc. | M — Option exercise | 66.3K | — | |
| 2025-09-24 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 6.0K | $55.37 | $332K |
| 2025-08-11 | TARS | Tarsus Pharmaceuticals, Inc. | S — Open-market sale | 6.0K | $50.00 | $300K |
Azamian Bobak R. is a corporate insider — currently tracked as President/CEO and Board Chair, Director of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($3.61M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Azamian Bobak R. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.